Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Breast Cancer

  Free Subscription


Articles published in Gene

Retrieve available abstracts of 81 articles:
HTML format



Single Articles


    September 2020
  1. ZHANG XY, Mao L
    Circular RNA Circ_0000442 Acts as a Sponge of MiR-148b-3p to Suppress Breast Cancer via PTEN/PI3K/Akt Signaling Pathway.
    Gene. 2020 Sep 3:145113. doi: 10.1016/j.gene.2020.145113.
    PubMed     Abstract available


    August 2020
  2. WANG J, Yang Z, Zhang C, Ouyang J, et al
    A Four-Gene Signature in the Tumor Microenvironment That Significantly Associates with the Prognosis of Patients with Breast Cancer.
    Gene. 2020 Aug 10:145049. doi: 10.1016/j.gene.2020.145049.
    PubMed    


  3. DOMINGUEZ-DE-LA-CRUZ E, de Lourdes Munoz M, Perez-Munoz A, Garcia-Hernandez N, et al
    Reduced mitochondrial DNA copy number is associated with the haplogroup, and some clinical features of breast cancer in Mexican patients.
    Gene. 2020 Aug 9:145047. doi: 10.1016/j.gene.2020.145047.
    PubMed     Abstract available


  4. RAJAGOPAL T, Seshachalam A, Akshaya RL, Kumar Rathnam K, et al
    Association of HOTAIR (rs920778 and rs1899663) and NME1 (rs16949649 and rs2302254) gene polymorphisms with breast cancer risk in India.
    Gene. 2020 Aug 8:145033. doi: 10.1016/j.gene.2020.145033.
    PubMed     Abstract available


  5. NOLAN J, Mahdi AF, Dunne CP, Kiely PA, et al
    Collagen and fibronectin promote an aggressive cancer phenotype in breast cancer cells but drive autonomous gene expression patterns.
    Gene. 2020 Aug 2:145024. doi: 10.1016/j.gene.2020.145024.
    PubMed     Abstract available


    July 2020
  6. JAMALZEI B, Karami Tehrani FS, Atri M
    Evaluation of LDL receptor and Scavenger Receptor, Class B, Type 1 in the malignant and benign breast tumors: The correlation with the expression of miR-199a-5p, miR-199b-5p and miR-455-5p.
    Gene. 2020;749:144720.
    PubMed     Abstract available


  7. XU T, Zhang S, Qiu D, Li X, et al
    Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis.
    Gene. 2020;759:144972.
    PubMed     Abstract available


  8. KUSOGLU A, Bagca BG, Ay NPO, Gunduz C, et al
    Telomerase inhibition regulates EMT mechanism in breast cancer stem cells.
    Gene. 2020 Jul 29:145001. doi: 10.1016/j.gene.2020.145001.
    PubMed     Abstract available


  9. GUO L, Chen B, Zhang G, Wang Y, et al
    The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
    Gene. 2020 Jul 22:144970. doi: 10.1016/j.gene.2020.144970.
    PubMed     Abstract available


  10. DU JX, Chen C, Luo YH, Cai JL, et al
    Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Gene. 2020 Jul 21:144974. doi: 10.1016/j.gene.2020.144974.
    PubMed     Abstract available


    June 2020
  11. CAI Z, Zhang M, Boafo Kwantwi L, Bi X, et al
    Breast cancer cells promote self-migration by secreting interleukin 8 to induce NET formation.
    Gene. 2020 Jun 13:144902. doi: 10.1016/j.gene.2020.144902.
    PubMed    


  12. RAHMANI F, Taddayon Tabrizi A, Hashemian P, Alijannejad S, et al
    Role of regulatory miRNAs of the Wnt/ beta-catenin signaling pathway in tumorigenesis of breast cancer.
    Gene. 2020 Jun 10:144892. doi: 10.1016/j.gene.2020.144892.
    PubMed     Abstract available


    May 2020
  13. TENHUNEN J, Kokkola T, Huovinen M, Rahnasto-Rilla M, et al
    Impact of structurally diverse BET inhibitors on SIRT1.
    Gene. 2020;741:144558.
    PubMed     Abstract available


  14. JIA R, Zhao H, Jia M
    Identification of co-expression modules and potential biomarkers of breast cancer by WGCNA.
    Gene. 2020;750:144757.
    PubMed     Abstract available


    April 2020
  15. SUN L, Shi C, Liu S, Zhang E, et al
    Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/beta-catenin/EMT signalling axis.
    Gene. 2020 Apr 13:144657. doi: 10.1016/j.gene.2020.144657.
    PubMed     Abstract available


    March 2020
  16. WU Y, Huang D, Zhang H, Weng X, et al
    The frequency of PTEN germline mutations in Chinese breast cancer patients: the PTEN gene may not be closely associated with breast cancer in the Chinese population.
    Gene. 2020 Mar 28:144630. doi: 10.1016/j.gene.2020.144630.
    PubMed     Abstract available


    February 2020
  17. DAI J, Chen Y, Gong Y, Gu D, et al
    Association of microRNA-27a rs895819 polymorphism with the risk of cancer: An updated meta-analysis.
    Gene. 2020;728:144185.
    PubMed     Abstract available


  18. DOULABI MSH, Ghaedi K, Ranji N, Koohpar ZK, et al
    rs1016860 of BCL2 3'UTR associates with hsa-miR-629-5p binding potential in breast cancer and gastric cancer in isfahan population.
    Gene. 2020 Feb 17:144457. doi: 10.1016/j.gene.2020.144457.
    PubMed     Abstract available


  19. RAHMANI F, Ferns GA, Talebian S, Nourbakhsh M, et al
    Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer.
    Gene. 2020 Feb 8:144459. doi: 10.1016/j.gene.2020.144459.
    PubMed     Abstract available


  20. ABUBAKR BABTEEN N, Fawzy MS, Alelwani W, Ayiad Alharbi R, et al
    Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes.
    Gene. 2020 Feb 7:144435. doi: 10.1016/j.gene.2020.144435.
    PubMed     Abstract available


  21. NAJJARY S, Mohammadzadeh R, Mokhtarzadeh A, Mohammadi A, et al
    Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer.
    Gene. 2020 Feb 5:144453. doi: 10.1016/j.gene.2020.144453.
    PubMed     Abstract available


    January 2020
  22. ZHANG H, Cui X, Cao A, Li X, et al
    ITGA3 interacts with VASP to regulate stemness and epithelial-mesenchymal transition of breast cancer cells.
    Gene. 2020 Jan 25:144396. doi: 10.1016/j.gene.2020.144396.
    PubMed     Abstract available


  23. POURBAGHER R, Akhavan-Niaki H, Jorsaraei SGA, Fattahi S, et al
    Targeting LA7 breast cancer stem cells of rat through repressing the genes of stemness-related transcription factors using three different biological fluids.
    Gene. 2020 Jan 21:144381. doi: 10.1016/j.gene.2020.144381.
    PubMed     Abstract available


  24. WANG X, Su D, Qin Z, Chen Z, et al
    Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.
    Gene. 2020;722:144057.
    PubMed     Abstract available


    December 2019
  25. DASTMALCHI N, Safaralizadeh R, Baradaran B, Hosseinpourfeizi M, et al
    An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer.
    Gene. 2019 Dec 26:144301. doi: 10.1016/j.gene.2019.144301.
    PubMed     Abstract available


  26. XIE W, Zhang H, Qin S, Zhang J, et al
    The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Gene. 2019;720:144088.
    PubMed     Abstract available


  27. AL-EITAN LN, Rababa'h DM
    Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: a genotype-phenotype study.
    Gene. 2019 Dec 10:144281. doi: 10.1016/j.gene.2019.144281.
    PubMed     Abstract available


    November 2019
  28. MORAIS-RODRIGUES F, Silv Erio-Machado R, Kato RB, Rodrigues DLN, et al
    Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
    Gene. 2019 Nov 21:144168. doi: 10.1016/j.gene.2019.144168.
    PubMed     Abstract available


    September 2019
  29. QI L, Yao Y, Zhang T, Feng F, et al
    A four-mRNA model to improve the prediction of breast cancer prognosis.
    Gene. 2019 Sep 4:144100. doi: 10.1016/j.gene.2019.144100.
    PubMed     Abstract available


  30. ZOU X, Li M, Huang Z, Zhou X, et al
    Circulating miR-532-502 cluster derived from chromosome X as biomarkers for diagnosis of breast cancer.
    Gene. 2019 Sep 4:144104. doi: 10.1016/j.gene.2019.144104.
    PubMed     Abstract available


    August 2019
  31. WANG H, Xu B, Shi J
    N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
    Gene. 2019 Aug 24:144076. doi: 10.1016/j.gene.2019.144076.
    PubMed     Abstract available


  32. ORS KUMOGLU G, Doskaya M, Gulce Iz S
    The biomarker features of miR-145-3p determined via meta-analysis validated by qRT-PCR in metastatic cancer cell lines.
    Gene. 2019;710:341-353.
    PubMed     Abstract available


  33. NAZIR SU, Kumar R, Singh A, Khan A, et al
    Corrigendum to "Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor" [Gene 711 (2019) 143952].
    Gene. 2019 Aug 1:144013. doi: 10.1016/j.gene.2019.144013.
    PubMed    


    July 2019
  34. TOKGUN PE, Tokgun O, Kurt S, Tomatir AG, et al
    MYC-driven regulation of long non-coding RNA profiles in breast cancer cells.
    Gene. 2019 Jul 18:143955. doi: 10.1016/j.gene.2019.143955.
    PubMed     Abstract available


  35. RAMEZANI S, Sharafshah A, Mirzanejad L, Hadavi M, et al
    Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
    Gene. 2019;712:143954.
    PubMed     Abstract available


    June 2019
  36. NAZIR SU, Kumar R, Singh A, Khan A, et al
    Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor.
    Gene. 2019 Jun 29:143952. doi: 10.1016/j.gene.2019.143952.
    PubMed     Abstract available


  37. YARAHMADI S, Abdolvahabi Z, Hesari Z, Tavakoli-Yaraki M, et al
    Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.
    Gene. 2019 Jun 17. pii: S0378-1119(19)30589-X. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available


  38. FENG T, Zhang P, Sun Y, Wang Y, et al
    High throughput sequencing identifies breast cancer-secreted exosomal LncRNAs initiating pulmonary pre-metastatic niche formation.
    Gene. 2019 Jun 6. pii: S0378-1119(19)30552-9. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available


  39. KASA P, Farran B, Prasad GLV, Nagaraju GP, et al
    Aquaporins in female specific cancers.
    Gene. 2019;700:60-64.
    PubMed     Abstract available


    May 2019
  40. XU X, Yang J, Zhou W, Wang L, et al
    Genetic variations within alternative splicing associated genes are associated with breast cancer susceptibility in Chinese women.
    Gene. 2019 May 9. pii: S0378-1119(19)30484-6. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available


    April 2019
  41. WU G, Niu M, Qin J, Wang Y, et al
    Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells.
    Gene. 2019 Apr 16. pii: S0378-1119(19)30344-0. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available


  42. BU Y, Shi L, Yu D, Liang Z, et al
    CDCA8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells.
    Gene. 2019;703:1-6.
    PubMed     Abstract available


    March 2019
  43. MUKUND V, Saddala MS, Farran B, Mannavarapu M, et al
    Molecular docking studies of angiogenesis target protein HIF-1alpha and genistein in breast cancer.
    Gene. 2019;701:169-172.
    PubMed     Abstract available


  44. SAFARI MR, Rezaei FM, Dehghan A, Noroozi R, et al
    Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population.
    Gene. 2019 Mar 22. pii: S0378-1119(19)30293-8. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available


  45. AFSHAR E, Hashemi-Arabi M, Salami S, Peirouvi T, et al
    Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts.
    Gene. 2019 Mar 18. pii: S0378-1119(19)30271-9. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available


  46. ZHANG L, Chen T, Yan L, Xu H, et al
    MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.
    Gene. 2019 Mar 13. pii: S0378-1119(19)30200-8. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available


    February 2019
  47. YOUNES N, Zayed H
    Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.
    Gene. 2019;684:154-164.
    PubMed     Abstract available


    January 2019
  48. ZHONG C, Mai Y, Gao H, Zhou W, et al
    Mitochondrial targeting of TR3 is involved in TPA induced apoptosis in breast cancer cells.
    Gene. 2019 Jan 11. pii: S0378-1119(19)30032-0. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


    November 2018
  49. LI J, Li B, Jiang Q, Zhang Y, et al
    Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
    Gene. 2018;677:211-227.
    PubMed     Abstract available


  50. ORANGI E, Motovali-Bashi M
    Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Gene. 2018;687:272-279.
    PubMed     Abstract available


    October 2018
  51. ZHOU J, Pei Y, Chen G, Cao C, et al
    SPC24 Regulates breast cancer progression by PI3K/AKT signaling.
    Gene. 2018;675:272-277.
    PubMed     Abstract available


  52. MA R, Zhai X, Zhu X, Zhang L, et al
    LINC01585 functions as a regulator of gene expression by the CAMP/CREB signaling pathway in breast cancer.
    Gene. 2018 Oct 23. pii: S0378-1119(18)31102-8. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  53. JAHANGIRI R, Jamialahmadi K, Gharib M, Razavi AE, et al
    Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
    Gene. 2018 Oct 22. pii: S0378-1119(18)31099-0. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  54. SHI S, Chen X, Liu H, Yu K, et al
    LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/beta-catenin pathway.
    Gene. 2018 Oct 6. pii: S0378-1119(18)31039-4. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


    August 2018
  55. MAQBOOL SN, Nazeer HS, Rafiq M, Javed A, et al
    Bridging the gap by discerning SNPs in linkage disequilibrium and their role in breast cancer.
    Gene. 2018 Aug 14. pii: S0378-1119(18)30762-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  56. JANAKI RAMAIAH M, Vaishnave S
    BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    Gene. 2018 Aug 7. pii: S0378-1119(18)30872-2. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


    July 2018
  57. SHERAFATIAN M
    Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
    Gene. 2018 Jul 25. pii: S0378-1119(18)30836-9. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  58. SADAF, Habib M, Khan MA, Najm MZ, et al
    Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India.
    Gene. 2018 Jul 12. pii: S0378-1119(18)30807-2. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  59. JIANG M, Xiao Y, Liu D, Luo N, et al
    Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer.
    Gene. 2018 Jul 4. pii: S0378-1119(18)30773-X. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


    June 2018
  60. AL-OTHMAN N, Hammad H, Ahram M
    Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.
    Gene. 2018 Jun 28. pii: S0378-1119(18)30755-8. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  61. ULKER D, Ersoy YE, Gucin Z, Muslumanoglu M, et al
    Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation.
    Gene. 2018 Jun 13. pii: S0378-1119(18)30687-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  62. HESARI Z, Nourbakhsh M, Hosseinkhani S, Abdolvahabi Z, et al
    Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
    Gene. 2018 Jun 7. pii: S0378-1119(18)30672-3. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


    May 2018
  63. XU J, Zhang W, Tang L, Chen W, et al
    Epithelial-mesenchymal transition induced PAI-1 is associated with prognosis of triple-negative breast cancer patients.
    Gene. 2018 May 23. pii: S0378-1119(18)30586-9. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  64. RAHMAN S, Zayed H
    Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes.
    Gene. 2018 May 16. pii: S0378-1119(18)30534-1. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  65. BAGHI N, Bakhshinejad B, Keshavarz R, Babashah S, et al
    Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
    Gene. 2018 May 10. pii: S0378-1119(18)30508-0. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  66. REZAIE Z, Ardeshirylajimi A, Ashkezari MD
    Improved anticancer properties of stem cells derived exosomes by prolonged release from PCL nanofibrous structure.
    Gene. 2018 May 2. pii: S0378-1119(18)30480-3. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


    March 2018
  67. FEI HR, Li ZJ, Ying-Zhang, Yue-Liu, et al
    HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells.
    Gene. 2018;647:39-47.
    PubMed     Abstract available


  68. RAGHAVAN S, Venkatraman G, Rayala SK
    Cloning and functional characterization of human Pak1 promoter by steroid hormones.
    Gene. 2018;646:120-128.
    PubMed     Abstract available


  69. XIAO B, Zhang W, Chen L, Hang J, et al
    Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Gene. 2018 Mar 5. pii: S0378-1119(18)30238-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


    February 2018
  70. HEYDARI N, Nikbakhsh N, Sadeghi F, Farnoush N, et al
    Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer.
    Gene. 2018 Feb 20. pii: S0378-1119(18)30167-7. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  71. SINGH PK, Mistry K, Haritha C, Rank DN, et al
    Exploring the deleterious SNPs in XRCC4 gene using computational approach and studying their association with breast cancer in the population of West India.
    Gene. 2018 Feb 13. pii: S0378-1119(18)30176-8. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  72. GHALI R, Al-Mutawa MA, Al-Ansari AK, Zaied S, et al
    Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Gene. 2018 Feb 4. pii: S0378-1119(18)30140-9. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  73. LI XP, Lan JY, Liu DQ, Zhou H, et al
    OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.
    Gene. 2018 Feb 1. pii: S0378-1119(18)30121-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


    January 2018
  74. CHEN J, Jiang Y, Zhou J, Liu S, et al
    Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer.
    Gene. 2018 Jan 24. pii: S0378-1119(18)30085-4. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


  75. DANESH H, Hashemi M, Bizhani F, Hashemi SM, et al
    Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 polymorphisms and the risk of breast cancer in a sample of Iranian population.
    Gene. 2018 Jan 6. pii: S0378-1119(18)30032-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available


    December 2017
  76. KAR S, Patra SK
    Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Gene. 2017 Dec 1. pii: S0378-1119(17)31043-0. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available


    November 2017
  77. KLASSEN LMB, Chequin A, Manica GCM, Biembengut IV, et al
    MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
    Gene. 2017 Nov 18. pii: S0378-1119(17)31018-1. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available


  78. PENG R, Luo C, Guo Q, Cao J, et al
    Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.
    Gene. 2017 Nov 13. pii: S0378-1119(17)30956-3. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available


    October 2017
  79. JANAKI RAMAIAH M, Naushad SM, Lavanya PON, Gayatri A, et al
    Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Gene. 2017 Oct 13. pii: S0378-1119(17)30831-4. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available


  80. ZHOU L, Gao HF, Liu DS, Feng JY, et al
    Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
    Gene. 2017 Oct 9. pii: S0378-1119(17)30833-8. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available


    September 2017
  81. LAHIRI DK, Maloney B, Sambamurti K
    When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author.
    Gene. 2017 Sep 6. pii: S0378-1119(17)30646-7. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: